Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 2Somatostatinoma 1Neuroblastoma 1Medulloblastoma 1

Interventions

gallium Ga 68 dotatate 4fluorodopa F 18 2Magnetic Resonance Spectroscopy 2pertuzumab 1pentetreotide 1olaparib 1lutetium Lu 177 dotatate 1arginyllysine 1Whole Body Imaging 1Tretinoin 1Nivolumab 1Isotretinoin 1Furosemide 1Erlotinib Hydrochloride 1Amino Acids 190Y-octreotide, DOTA-Tyr(3)- 14-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid 13-fluorobenzylguanidine 1(18F)GTP1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × pentetreotide × NET × Clear all
NCT01869725 2021-09-22

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

University of Iowa

Phase 2 Completed
68 enrolled 8 charts
CNSEndocrineNET

Medulloblastoma, Neuroblastoma, Somatostatinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡